Chiara D’Antonio

582 total citations
15 papers, 423 citations indexed

About

Chiara D’Antonio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chiara D’Antonio has authored 15 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Chiara D’Antonio's work include Cancer Treatment and Pharmacology (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Chiara D’Antonio is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Chiara D’Antonio collaborates with scholars based in Italy. Chiara D’Antonio's co-authors include Paolo Marchetti, Adriana Romiti, Maria Rita Migliorino, Alberto Fulvi, Antonio Passaro, Serena Ricciardi, Ester Del Signore, Filippo de Marinis, Bruno Gori and Viola Barucca and has published in prestigious journals such as Frontiers in Immunology, Journal of Thoracic Oncology and International Journal of Cardiology.

In The Last Decade

Chiara D’Antonio

14 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara D’Antonio Italy 11 247 160 143 101 50 15 423
Yifan Cao China 14 290 1.2× 136 0.8× 175 1.2× 95 0.9× 79 1.6× 29 529
Karel Cwiertka Czechia 10 247 1.0× 123 0.8× 115 0.8× 108 1.1× 48 1.0× 45 436
Coralie Moncharmont France 9 204 0.8× 160 1.0× 157 1.1× 83 0.8× 46 0.9× 26 437
Ruslan D. Novosiadly United States 9 346 1.4× 114 0.7× 207 1.4× 114 1.1× 26 0.5× 22 540
Erion Dobi France 14 217 0.9× 147 0.9× 74 0.5× 111 1.1× 36 0.7× 31 356
Jelena Urosevic Spain 8 227 0.9× 72 0.5× 221 1.5× 111 1.1× 37 0.7× 10 462
Collin M. Labak United States 11 169 0.7× 78 0.5× 181 1.3× 131 1.3× 44 0.9× 36 504
Giuseppa Ferraro Italy 10 261 1.1× 205 1.3× 132 0.9× 101 1.0× 27 0.5× 19 421
Haidong Wang China 7 170 0.7× 160 1.0× 195 1.4× 159 1.6× 19 0.4× 10 447
Yuki Katsura Japan 7 279 1.1× 98 0.6× 188 1.3× 117 1.2× 73 1.5× 19 494

Countries citing papers authored by Chiara D’Antonio

Since Specialization
Citations

This map shows the geographic impact of Chiara D’Antonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara D’Antonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara D’Antonio more than expected).

Fields of papers citing papers by Chiara D’Antonio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara D’Antonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara D’Antonio. The network helps show where Chiara D’Antonio may publish in the future.

Co-authorship network of co-authors of Chiara D’Antonio

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara D’Antonio. A scholar is included among the top collaborators of Chiara D’Antonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara D’Antonio. Chiara D’Antonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
D’Antonio, Chiara, et al.. (2024). Sjögren syndrome induced by anti PDL-1 treatment for TNBC: case report and review of literature. Frontiers in Immunology. 15. 1417444–1417444.
2.
Marchetti, Paolo, Annalisa Milano, Chiara D’Antonio, et al.. (2016). Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial. Clinical Colorectal Cancer. 15(4). 377–380. 23 indexed citations
3.
Romiti, Adriana, Michela Roberto, Chiara D’Antonio, et al.. (2016). The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs. 27(10). 1044–1049. 13 indexed citations
4.
D’Antonio, Chiara, Concetta Elisa Onesti, Rosa Falcone, et al.. (2016). A rare case of palatin tonsillar metastasis from small cell lung cancer. Translational Lung Cancer Research. 5(6). 709–711. 4 indexed citations
5.
Falcone, Rosa, Michela Roberto, Chiara D’Antonio, et al.. (2016). High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art. Digestive and Liver Disease. 48(12). 1503–1505. 38 indexed citations
6.
Roberto, Michela, Adriana Romiti, Concetta Elisa Onesti, et al.. (2015). A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer. Anti-Cancer Drugs. 27(2). 106–111. 13 indexed citations
7.
Romiti, Adriana, Salvatore Raffa, Michela Roberto, et al.. (2014). Circulating Tumor Cells Count Predicts Survival in Colorectal Cancer Patients. Journal of Gastrointestinal and Liver Diseases. 23(3). 279–284. 40 indexed citations
8.
D’Antonio, Chiara, Annalisa Milano, Concetta Elisa Onesti, et al.. (2014). Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.. PubMed. 34(10). 5241–50. 13 indexed citations
9.
D’Antonio, Chiara, Antonio Passaro, Bruno Gori, et al.. (2014). Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Therapeutic Advances in Medical Oncology. 6(3). 101–114. 162 indexed citations
10.
Conti, Elena, Adriana Romiti, Beatrice Musumeci, et al.. (2013). Arterial thrombotic events and acute coronary syndromes with cancer drugs: Are growth factors the missed link?. International Journal of Cardiology. 167(6). 2421–2429. 15 indexed citations
11.
Romiti, Adriana, et al.. (2013). Metronomic chemotherapy for cancer treatment: a decade of clinical studies. Cancer Chemotherapy and Pharmacology. 72(1). 13–33. 69 indexed citations
12.
Romiti, Adriana, Massimo Milione, Luigi Ruco, et al.. (2012). Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.. PubMed. 32(1). 115–9. 4 indexed citations
13.
D’Antonio, Chiara, et al.. (2012). Complete Regression of a Non-small Cell Lung Cancer Choroidal Metastasis with Intravitreal Bevacizumab. Journal of Thoracic Oncology. 7(2). 468–469. 11 indexed citations
14.
Romiti, Adriana, et al.. (2012). Chemotherapy for the Biliary Tract Cancers: Moving Toward Improved Survival Time. Journal of Gastrointestinal Cancer. 43(3). 396–404. 15 indexed citations
15.
Romiti, Adriana, Chiara D’Antonio, Vittoria Mastromarino, et al.. (2012). Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome. Current Signal Transduction Therapy. 7(3). 265–288. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026